Liffe CEO Garry Jones on his plans for the exchange following the collpase of the NYSE/DB merger.
The collapse of the deal to merger Liffe and Eurex,
Europe’s two largest derivatives exchanges, has
maintained the status quo for now. But with the London Stock
Exchange in exclusive talks to buy LCH.Clearnet, the London
Metal Exchange up for grabs and new regulation coming into
force across Europe, there is little time to reflect on the
failed merger. Galen Stops talks to Liffe’s
Garry Jones about the failed merger and the outlook for
European exchange traded derivatives.
Garry Jones, global head of Liffe, NYSE
Euronext’s derivatives subsidiary, is not a man
to let a setback like a failed merger get in the way of his
ambition. Fresh from the collapse of a deal that would have
seen Liffe join forces with German rival Eurex, he is as
bullish as ever as he sets his sights on growing the exchange
as a stand-alone business.
This article is available to subscribers and registered users
Please log in to continue reading.
Not yet registered? Take a free trial.
If you have already taken a free trial you
have ongoing access to the analysis section of FOW.com including this story.
Log in using your details below to read.
Already have an account? |